Tejnaksh Healthcare Limited (BOM:539428)
India · Delayed Price · Currency is INR 15.09
-0.04 (-0.26%)
At close: Jun 17, 2026
Tejnaksh Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 107.87 | 128.97 | 121.75 | 117.27 | 126.76 |
Other Revenue | - | 1.24 | 0.81 | 1.42 | 0.64 |
| 107.87 | 130.21 | 122.56 | 118.69 | 127.4 | |
Revenue Growth (YoY) | -17.16% | 6.24% | 3.26% | -6.84% | 6.52% |
Cost of Revenue | 24.11 | 35.87 | 29.46 | 31.25 | 30.4 |
Gross Profit | 83.76 | 94.34 | 93.1 | 87.44 | 97 |
Selling, General & Admin | - | 0.22 | 0.58 | 0.34 | 0.21 |
Other Operating Expenses | 55.99 | 52.13 | 55.49 | 48.81 | 48.17 |
Operating Expenses | 70.28 | 61.45 | 65.12 | 57.89 | 55.03 |
Operating Income | 13.49 | 32.89 | 27.98 | 29.55 | 41.97 |
Interest Expense | -0.96 | -3.76 | -6.41 | -6.08 | -4.02 |
Interest & Investment Income | - | 1.5 | 2.05 | 1.33 | 0.62 |
Currency Exchange Gain (Loss) | - | -0.02 | -0.04 | 0.01 | - |
Other Non Operating Income (Expenses) | 3.93 | 1.31 | 0.17 | 0.31 | -0.52 |
EBT Excluding Unusual Items | 16.46 | 31.91 | 23.75 | 25.13 | 38.06 |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.45 |
Pretax Income | 16.46 | 31.91 | 23.75 | 25.13 | 37.61 |
Income Tax Expense | 4.65 | 9.61 | 6.11 | 7.21 | 9.5 |
Earnings From Continuing Operations | 11.81 | 22.31 | 17.64 | 17.91 | 28.11 |
Minority Interest in Earnings | 0.47 | 0.97 | 0.12 | -1.09 | -0.88 |
Net Income | 12.28 | 23.28 | 17.76 | 16.83 | 27.24 |
Net Income to Common | 12.28 | 23.28 | 17.76 | 16.83 | 27.24 |
Net Income Growth | -47.24% | 31.07% | 5.54% | -38.22% | 32.67% |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 |
Shares Change (YoY) | -0.88% | - | - | - | - |
EPS (Basic) | 0.61 | 1.15 | 0.87 | 0.83 | 1.34 |
EPS (Diluted) | 0.61 | 1.15 | 0.87 | 0.83 | 1.34 |
EPS Growth | -46.77% | 31.07% | 5.54% | -38.22% | 32.67% |
Free Cash Flow | 12.01 | 1.35 | 33.03 | 12.96 | 1.31 |
Free Cash Flow Per Share | 0.60 | 0.07 | 1.63 | 0.64 | 0.06 |
Gross Margin | 77.65% | 72.46% | 75.96% | 73.67% | 76.14% |
Operating Margin | 12.50% | 25.26% | 22.83% | 24.90% | 32.94% |
Profit Margin | 11.39% | 17.88% | 14.49% | 14.18% | 21.38% |
Free Cash Flow Margin | 11.13% | 1.04% | 26.95% | 10.92% | 1.03% |
EBITDA | 27.77 | 41.84 | 36.84 | 38.07 | 48.27 |
EBITDA Margin | 25.74% | 32.13% | 30.06% | 32.07% | 37.88% |
D&A For EBITDA | 14.28 | 8.95 | 8.86 | 8.51 | 6.3 |
EBIT | 13.49 | 32.89 | 27.98 | 29.55 | 41.97 |
EBIT Margin | 12.50% | 25.26% | 22.83% | 24.90% | 32.94% |
Effective Tax Rate | 28.25% | 30.11% | 25.73% | 28.70% | 25.25% |
Revenue as Reported | 111.8 | 133.01 | 124.82 | 120.34 | 128.23 |
Advertising Expenses | - | 0.2 | 0.57 | 0.26 | 0.12 |